Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

25 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma.
MacManus MP, Seymour JF, Tsang H, Fisher R, Keane C, Sabdia MB, Law SC, Gunawardana J, Nath K, Kazakoff SH, Marques-Piubelli ML, Duenas DE, Green MR, Roos D, O'Brien P, McCann A, Tsang R, Davis S, Christie D, Cheah C, Amanuel B, Cochrane T, Butler J, Johnston A, Shanavas M, Li L, Vajdic C, Kridel R, Shelton V, Hershenfield S, Baetz T, Lebrun D, Johnson N, Brodtkorb M, Ludvigsen M, d'Amore F, Thompson ER, Blombery P, Gandhi MK, Tobin JWD. MacManus MP, et al. Among authors: shanavas m. EBioMedicine. 2024 Dec;110:105468. doi: 10.1016/j.ebiom.2024.105468. Epub 2024 Dec 3. EBioMedicine. 2024. PMID: 39631145 Free PMC article. Clinical Trial.
Intra-tumoral and peripheral blood TIGIT and PD-1 as immune biomarkers in nodular lymphocyte predominant Hodgkin lymphoma.
Gunawardana J, Law SC, Sabdia MB, Fennell É, Hennessy A, Leahy CI, Murray PG, Bednarska K, Brosda S, Trotman J, Berkahn L, Zaharia A, Birch S, Burgess M, Talaulikar D, Lee JN, Jude E, Hawkes EA, Jain S, Nath K, Snell C, Swain F, Tobin JWD, Keane C, Shanavas M, Blyth E, Steidl C, Savage K, Farinha P, Boyle M, Meissner B, Green MR, Vega F, Gandhi MK. Gunawardana J, et al. Among authors: shanavas m. Am J Hematol. 2024 Nov;99(11):2096-2107. doi: 10.1002/ajh.27459. Epub 2024 Aug 17. Am J Hematol. 2024. PMID: 39152767
The clinical features, management and outcomes of lymphoma in pregnancy: A multicentre study by the Australasian Lymphoma Alliance.
Di Ciaccio PR, Mills G, Shipton MJ, Campbell B, Gregory G, Langfield J, Greenwood M, McKeague S, Shanavas M, Eslick R, Kidson-Gerber G, Smallbone P, Tang C, Morris K, Bilmon I, Yannakou CK, Badoux X, Berkahn L, Farina S, Mason KD, Motum P, Goss K, Hamad N. Di Ciaccio PR, et al. Among authors: shanavas m. Br J Haematol. 2023 Jun;201(5):887-896. doi: 10.1111/bjh.18727. Epub 2023 Mar 7. Br J Haematol. 2023. PMID: 36880558
Capturing the lived experiences of women with lymphoma in pregnancy: a qualitative study.
Mills GS, Di Ciaccio PR, Tang C, Chadwick V, Mason KD, Campbell BA, Shipton MJ, Shanavas M, Morris KL, Greenwood M, Langfield J, Kidson-Gerber G, Eslick R, Badoux X, Yannakou CK, Gangatharan SA, Bilmon I, Hamad N. Mills GS, et al. Among authors: shanavas m. Leuk Lymphoma. 2023 Feb;64(2):319-328. doi: 10.1080/10428194.2022.2148376. Epub 2022 Nov 24. Leuk Lymphoma. 2023. PMID: 36423348
Intratumoral T-cell receptor repertoire is predictive of interim PET scan results in patients with diffuse large B-cell lymphoma treated with rituximab/cyclophosphamide/doxorubicin/prednisolone/vincristine (R-CHOP) chemoimmunotherapy.
Shanavas M, Law SC, Hertzberg M, Hicks RJ, Seymour JF, Li Z, Merida de Long L, Nath K, Sabdia MB, Gunawardana J, Gandhi MK, Keane C. Shanavas M, et al. Clin Transl Immunology. 2021 Oct 27;10(11):e1351. doi: 10.1002/cti2.1351. eCollection 2021. Clin Transl Immunology. 2021. PMID: 34745610 Free PMC article.
Intratumoral T cells have a differential impact on FDG-PET parameters in follicular lymphoma.
Nath K, Law SC, Sabdia MB, Gunawardana J, de Long LM, Sester D, Shanavas M, Tsang H, Tobin JWD, Halliday SJ, Hernandez A, Cross D, Bird RJ, Jain S, Keane C, Talaulikar D, Trotman J, Law P, Gandhi MK. Nath K, et al. Among authors: shanavas m. Blood Adv. 2021 Jun 22;5(12):2644-2649. doi: 10.1182/bloodadvances.2020004051. Blood Adv. 2021. PMID: 34156439 Free PMC article.
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-Thalassemia.
Cappellini MD, Viprakasit V, Taher AT, Georgiev P, Kuo KHM, Coates T, Voskaridou E, Liew HK, Pazgal-Kobrowski I, Forni GL, Perrotta S, Khelif A, Lal A, Kattamis A, Vlachaki E, Origa R, Aydinok Y, Bejaoui M, Ho PJ, Chew LP, Bee PC, Lim SM, Lu MY, Tantiworawit A, Ganeva P, Gercheva L, Shah F, Neufeld EJ, Thompson A, Laadem A, Shetty JK, Zou J, Zhang J, Miteva D, Zinger T, Linde PG, Sherman ML, Hermine O, Porter J, Piga A; BELIEVE Investigators. Cappellini MD, et al. N Engl J Med. 2020 Mar 26;382(13):1219-1231. doi: 10.1056/NEJMoa1910182. N Engl J Med. 2020. PMID: 32212518 Clinical Trial.
Revisiting the cytotoxicity of quantum dots: an in-depth overview.
Nikazar S, Sivasankarapillai VS, Rahdar A, Gasmi S, Anumol PS, Shanavas MS. Nikazar S, et al. Among authors: shanavas ms. Biophys Rev. 2020 Jun;12(3):703-718. doi: 10.1007/s12551-020-00653-0. Epub 2020 Mar 5. Biophys Rev. 2020. PMID: 32140918 Free PMC article. Review.
Silicon Quantum Dots: Promising Theranostic Probes for the Future.
Sivasankarapillai VS, Jose J, Shanavas MS, Marathakam A, Uddin MS, Mathew B. Sivasankarapillai VS, et al. Among authors: shanavas ms. Curr Drug Targets. 2019;20(12):1255-1263. doi: 10.2174/1389450120666190405152315. Curr Drug Targets. 2019. PMID: 30961492 Review.
25 results